William Steffes, MD
Dermatology · Deland, FLNPI 1578855300
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.2%), speaking fees and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Galderma Laboratories, L.p. at 46.4% of the total. 2025 is the largest year on record at $16,558, 8.9 times the $1,869 reported in 2019. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 830 payments — averaging $35.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$14K
- AbbVie$3K
- Regeneron Healthcare Solutions, Inc.$1K
- Novartis$1K
- Lilly USA, LLC$1K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $8K from 29 others
What the payments were for
- Speaking & faculty fees$13,20044%
- Travel & lodging$1330%
- Food & beverage$15,57852%
- Education$9133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 21 | $13,826 |
| AbbVie | 147 | $3,093 |
| Regeneron Healthcare Solutions, Inc. | 56 | $1,294 |
| Novartis | 79 | $1,271 |
| Lilly USA, LLC | 68 | $1,195 |
| E.r. Squibb & Sons, L.L.C. | 65 | $1,146 |
| Sanofi | 38 | $1,042 |
| Johnson & Johnson | 52 | $1,033 |
| UCB, Inc. | 49 | $1,026 |
| Pfizer | 66 | $936 |
| LEO Pharma Inc. | 35 | $904 |
| Sun Pharmaceutical Industries Inc. | 30 | $680 |
| Amgen | 19 | $444 |
| Mayne Pharma Commercial LLC | 37 | $399 |
| Genentech USA, Inc. | 14 | $278 |
| Sanofi-aventis U.S. LLC | 7 | $226 |
| Janssen Scientific Affairs, LLC | 2 | $143 |
| Almirall LLC | 5 | $106 |
| Dermavant Sciences, Inc. | 4 | $101 |
| Boehringer Ingelheim | 4 | $94 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $79 |
| Dermira, Inc. | 3 | $69 |
| Strata Skin Sciences, Inc. | 6 | $67 |
| Biofrontera Inc. | 3 | $64 |
| Botanix SB Inc | 3 | $60 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| Blueprint Medicines Corporation | 2 | $42 |
| Kerecis Limited | 2 | $31 |
| Bristol Myers Squibb | 1 | $24 |
| LNHC, Inc | 1 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Incyte Corporation | 1 | $15 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,825 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 19 | $169,175 |
| Dupixent PenDupilumab | 34 | $129,393 |
| Fluorouracil | 82 | $6,291 |
| Clobetasol Propionate | 115 | $5,923 |
| Tacrolimus | 20 | $4,786 |
| Fluocinonide | 103 | $4,313 |
| Ketoconazole | 223 | $3,961 |
| Metronidazole | 56 | $2,544 |
| Doxycycline Monohydrate | 89 | $1,950 |
| Calcipotriene | 11 | $1,611 |
| Triamcinolone Acetonide | 150 | $1,487 |
| Dutasteride | 42 | $1,218 |
| Ciclopirox | 37 | $1,113 |
| ValacyclovirValacyclovir Hcl | 37 | $1,090 |
| Clindamycin Phosphate | 36 | $1,050 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Deland
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.